CN Stock MarketDetailed Quotes

301211 Hubei Biocause Heilen Pharmaceutical

Watchlist
  • 16.40
  • +0.03+0.18%
Market Closed May 31 15:00 CST
4.72BMarket Cap27.20P/E (TTM)

Hubei Biocause Heilen Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Hubei Biocause Heilen Pharmaceutical Earnings Date

Currency: CNY

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

138.06M

-28.57%
EPS(YoY)

0.13

-23.53%
Analyst Rating

No Data

Hubei Biocause Heilen Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

No Data

Hubei Biocause Heilen Pharmaceutical Earnings Reports

  • Hubei Biocause Heilen Pharmaceutical: 2024 First Quarter Report

    Apr 28 12:00 ET

  • Hendy Pharmaceuticals: 2023 Annual Report Summary

    Apr 22 12:00 ET

  • Hendy Pharmaceuticals: Annual Report 2023

    Apr 22 12:00 ET

  • Hendy Pharmaceuticals: 2023 Annual Results Forecast

    Jan 16 05:10 ET

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    %Chg